Plasma enterolignans are associated with lower colorectal adenoma risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 6, 2006, Pages 1132-1136

  Kuijsten, Anneleen ^a   Arts, Ilja C W ^a   Hollman, Peter C H ^a   Van't Veer, Pieter ^a   Kampman, Ellen ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ENTERODIOL; ENTEROLACTONE; ENTEROLIGNAN; LIGNAN DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD LEVEL; CANCER RISK; CASE CONTROL STUDY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOOD COMPOSITION; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; INTESTINE FLORA; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; TANDEM MASS SPECTROMETRY;

4-BUTYROLACTONE; ADENOMA; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; DIET; FEMALE; HUMANS; INCIDENCE; LIGNANS; MIDDLE AGED; NETHERLANDS; ODDS RATIO; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 33745683849     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0991     Document Type: Article

References (41)

1. Milder IEJ, Arts ICW, Putte B, Venema DP, Hollman PCH. Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 2005;93:393-402.
2. Axelson M, Sjoevall J, Gustafsson BE, Setchell KDR. Origin of lignans in mammals and identification of a precursor from plants. Nature 1982;298:659-60.
3. Borriello SP, Setchell KD, Axelson M, Lawson AM. Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 1985;58:37-43.
4. Heinonen S, Nurmi T, Liukkonen K, et al. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 2001;49:3178-86.
5. Dai Q, Franke AA, Jin F, et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 2002;11:815-21.
6. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phytooestrogens and breast cancer. Lancet 1997;350:990-4.
7. Pietinen P, Stumpf K, Mannisto S, et al. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 2001;10:339-44.
8. Boccardo F, Lunardi G, Guglielmini P, et al. Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 2004;40:84-9.
9. Olsen A, Knudsen KEB, Thomsen BL, et al. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol Biomarkers Prev 2004;13:2084-9.
10. Grace PB, Taylor JI, Low YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708.
11. Kilkkinen A, Virtamo J, Vartiainen E, et al. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 2004;108:277-80.
12. Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, et al. Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 2004;91:99-105.
13. Hulten K, Winkvist A, Lenner P, et al. An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 2002;41:168-76.
14. den Tonkelaar I, Keinan-Boker L, Van't Veer P, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:223-8.
15. Stattin P, Bylund A, Biessy C, et al. Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control 2004;15:1095-102.
16. Stattin P, Adlercreutz H, Tenkanen L, et al. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control. Int J Cancer 2002;99:124-9.
17. Kilkkinen A, Virtamo J, Virtanen MJ, et al. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidemiol Biomarkers Prev 2003;12:1209-12.
18. Hernandez BY, McDuffie K, Franke AA, Killeen J, Goodman MT. Plasma and dietary phytoestrogens and risk of premalignant lesions of the cervix. Nutr Cancer 2004;49:109-24.
19. Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 1999;202:91-100.
20. Prasad K. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 2000;9:220-5.
21. Sung MK, Lautens M, Thompson LU. Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells. Anticancer Res 1998;18:1405-8.
22. Adlercreutz H, Mousavi Y, Clark J, et al. Dietary phytoestrogens and cancer-in vitro and in vivo studies. J Steroid Biochem Mol Biol 1992;41:331-7.
23. Adlercreutz H, Bannwart C, Wahala K, et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993;44:147-53.
24. Webb AL, McCullough ML. Dietary lignans: potential role in cancer prevention. Nutr Cancer 2005;51:117-31.
25. Davies MJ, Bowey EA, Adlercreutz H, Rowland IR, Rumsby PC. Effects of soy or rye supplementation of high-fat diets on colon rumour development in azoxymethane-treated rats. Carcinogenesis 1999;20:927-31.
26. Jenab M, Thompson LU. The influence of flaxseed and lignans on colon carcinogenesis and β-glucuronidase activity. Carcinogenesis 1996;17:1343-8.
27. Oikarinen S, Heinonen SM, Nurmi T, Adlercreutz H, Mutanen M. No effect on adenoma formation in Min mice after moderate amount of flaxseed. Eur J Nutr 2005;44:273-80.
28. van Kranen HJ, Mortensen A, Sorensen IK, et al. Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in ApcMin mice. Nutr Cancer 2003;45:203-10.
29. Pajari AM, Smeds AI, Oikarinen SI, et al. The plant lignans matairesinol and secoisolariciresinol administered to Min mice do not protect against intestinal tumor formation. Cancer Lett 2005;233:309-14.
30. Tiemersma EW, Voskuil DW, Bunschoten A, et al. Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population. Cancer Causes Control 2004;15:225-36.
31. van den Donk M, Buijsse B, van den Berg SW, et al. Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study. Cancer Epidemiol Biomarkers Prev 2005;14:1562-6.
32. Ocke MC, Bueno-de-Mesquita HB, Pols MA, et al. The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients. Int J Epidemiol 1997;26:S49-58.
33. Ocke MC, Bueno-de-Mesquita HB, Goddijn HE, et al. The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol 1997;26:S37-48.
34. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-42.
35. Kuijsten A, Buijsman MNCP, Arts ICW, Mulder PP, Hollman PCH. A validated method for the quantification of enterodiol and enterolactone in plasma using isotope dilution liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2005;822:178-84.
36. Kilkkinen A, Pietinen P, Klaukka T, et al. Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 2002;155:472-7.
37. Setchell KD, Lawson AM, Borriello SP, et al. Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet 1981;2:4-7.
38. Marques-Vidal P, Ravasco P, Ermelinda Camilo M. Foodstuffs and colorectal cancer risk: a review. Clin Nutr 2006;25:14-36.
39. Kuijsten A, Arts ICW, Vree TB, Hollman PCH. Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 2005;135:795-801.
40. Zeleniuch-Jacquotte A, Adlercreutz H, Akhmedkhanov A, Toniolo P. Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period. Cancer Epidemiol Biomarkers Prev 1998;7:885-9.
41. Midgley R, Kerr D. Colorectal cancer. Lancet 1999;353:391-9.